Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $804.51 ($81K) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($81k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $802.67 | 16 | $13K | 15.9% |
| 2 | $803.58 | 30 | $24K | 29.9% |
| 3 | $804.51 | 2 | $2K | 2.0% |
| 4 | $805.34 | 5 | $4K | 5.0% |
| 5 | $806.53 | 15 | $12K | 15.0% |
| 6 | $807.50 | 17 |
| $14K |
| 17.0% |
| 7 | $808.11 | 15 | $12K | 15.1% |
| Total | $805.33 avg | 100 | $81K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |